Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edmund K Waller, MD PhD
Cambium Bio Limited
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Byers Eye Institute of Stanford University
Palo Alto, California, United States
- Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
- University of Michigan - Kellogg Clinical Research Center
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Duke University Eye Center
Durham, North Carolina, United States
- Oregon Health Sciences University - Casey Eye Institute
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2018
- Primary completion
- 12 Dec 2019
- Completion
- 20 Feb 2020
- Last update posted
- 12 Jun 2026
- Registered enrollment
- 64
- Registry id
- NCT03414645
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.